Savran Technologies
Non-invasive diagnostics based on capture and analysis of rare cells.
Launch date
Employees
Market cap
-
Enterprise valuation
$16—25m (Dealroom.co estimates Dec 2021.)
Cambridge Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | N/A | $543k | Debt |
* | N/A | $540k | Early VC |
* | N/A | $100k | Seed |
* | N/A | $104k | Debt |
* | N/A | $4.1m | Early VC |
| Total Funding | $4.7m | ||
Related Content
Recent News about Savran Technologies
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.